We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Pharma Equity Group A/s | LSE:0REU | London | Ordinary Share | DK0061155009 | PHARMA EQUITY GROUP ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.40 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investors, Nec | 0 | -24.61M | -0.0241 | -16.60 | 409.19M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 23/10/2024 | 08:28 | UKREG | Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained.. |
| 14/10/2024 | 06:17 | UKREG | Major shareholder announcement - Pharma Equity Group A/S |
| 14/10/2024 | 05:59 | UKREG | Managers’ transactions |
| 11/10/2024 | 06:37 | UKREG | Pharma Equity Group announces successful completion of directed issue of.. |
| 04/10/2024 | 11:52 | UKREG | Pharma Equity Group announces issuance of new shares in a direct issue |
| 04/10/2024 | 07:01 | UKREG | Registration of capital reduction by way of a reduction of the nominal.. |
| 16/8/2024 | 06:52 | UKREG | Consolidated Interim Report 1 January – 30 June 2024 |
| 16/7/2024 | 08:09 | UKREG | The Board of Directors' decision to issue convertible loans |
| 15/7/2024 | 14:22 | UKREG | Major shareholder announcement - Pharma Equity Group A/S |
| 15/7/2024 | 14:12 | UKREG | Major shareholder announcement - Pharma Equity Group A/S |
1 Year Pharma Equity Group A/s Chart |
Intraday Pharma Equity Group A/s Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
